![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Fcontent%2Fvol8%2Fissue3%2Fimages%2Fmedium%2Ffcr7024f3.gif)
Figure 3. Plasma testosterone concentrations during 24 hours after the application of two 37-cm2 permeation-enhanced transdermal patches applied nightly at 10 PM. Adapted from Meikle et al.26 Used by permission of Wiley-Liss, Inc, a subsidiary of John Wiley & Sons, Inc.